| Literature DB >> 19896511 |
Nimesh Gupta1, S R Santhosh, J Pradeep Babu, M M Parida, P V Lakshmana Rao.
Abstract
Japanese encephalitis (JE) is one of the leading causes of acute encephalopathy affecting children and adolescents in the tropics. JE virus (JEV) infection causes prominent neurological sequelae in approximately one-third of the survivors. In humans, the inflammatory response of CNS consequent to JEV induced viral encephalitis is mediated through chemokines released by various cells of CNS. In the present study, the chemokine profiles of mouse neuroblastoma cells (N2A) following JEV infection was analyzed by cDNA microarray followed by real-time RT-PCR. Eighty mRNA transcripts belonging to various functional classes exhibited significant alterations in gene expression. There was considerable induction of genes involved in apoptosis and anti-viral response. Modified levels of several transcripts involved in proinflammatory and anti-inflammatory processes exemplified the balance between opposing forces during JEV pathogenesis. Other genes displaying altered transcription included those associated with host translation, cellular metabolism, cell cycle, signal transduction, transcriptional regulation, protein trafficking, neurotransmitters, neuron maturation, protein modulators, ER stress and cytoskeletal proteins. The infection of neurons results in the synthesis of proinflammatory chemokines, which are early important mediators of leukocyte recruitment to sites of viral infection. Our results clearly suggest the implication of chemokines in neuropathogenesis of JEV infection leading to neurological sequelae. Pro- and anti-inflammatory agents targeted against chemokines such as CXCL10 may provide possible therapeutic modalities that can mitigate the morbidity associated with JEV infection of the CNS.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19896511 PMCID: PMC7126115 DOI: 10.1016/j.virusres.2009.10.018
Source DB: PubMed Journal: Virus Res ISSN: 0168-1702 Impact factor: 3.303
List of upregulated genes involved in pathogenesis of mouse neuroblastoma cells (N2A) infected with Japanese encephalitis virus.
| Accession no. | Gene name | Gene description | Fold change | |
|---|---|---|---|---|
| Cxcl10 | Chemokine (C–X–C motif) ligand 10 | 7.71 | 0.019 | |
| Ccl5 | Chemokine (C–C motif) ligand 5 | 6.10 | 0.041 | |
| Rsad2 | Viral hemorrhagic septicemia virus (VHSV) induced gene 1 | 5.11 | 0.049 | |
| Rtp4 | Receptor transporting protein 4 | 4.80 | 0.01 | |
| G1p2 | Interferon, alpha-inducible protein | 4.25 | 0.008 | |
| Usp18 | Ubiquitin specific protease 18 | 4.17 | 0.011 | |
| Oasl2 | 2′–5′ oligoadenylate synthetase-like 2 | 4.06 | 0.025 | |
| Oas1a | 2′–5′ oligoadenylate synthetase 1A | 3.39 | 0.092 | |
| Ifit3 | Interferon-induced protein with tetratricopeptide repeats 3 | 3.38 | 0.07 | |
| Oasl1 | 2′–5′ oligoadenylate synthetase-like 1 | 2.85 | 0.035 | |
| Atf3 | Activating transcription factor 3 | 2.71 | 0.033 | |
| Iigp2 | Interferon-g induced GTPase | 2.51 | 0.046 | |
| Parp14 | Poly(ADP-ribose) polymerase family, member 14 | 2.39 | 0.004 | |
| Chd6 | Chromodomain helicase DNA binding protein 6 | 2.27 | 0.084 | |
| Creld2 | Cysteine-rich with EGF-like domains 2 | 2.22 | 0.023 | |
| Sdf2l1 | Stromal cell-derived factor 2-like 1 | 2.21 | 0.005 | |
| Irgm | Interferon inducible protein 1 | 2.16 | 0.001 | |
| 2310016F22Rik | Hypothetical protein LOC71898 | 2.15 | 0.011 | |
| Bhlhb8 | Muscle, intestine and stomach expression 1 | 2.12 | 0.04 | |
| Ifit2 | Interferon-induced protein with tetratricopeptide repeats 2 | 2.11 | 0.011 | |
| Dnajb9 | DnaJ (Hsp40) homolog, subfamily B, member 9 | 2.10 | 3.96E-04 | |
| Isg20 | Interferon-stimulated protein | 2.02 | 0.031 | |
| A230097K15Rik | Hypothetical protein LOC231510 | 1.95 | 0.007 | |
| Ddit3 | DNA-damage inducible transcript 3 | 1.93 | 0.004 | |
| 1110007F12Rik | Hypothetical protein LOC68487 | 1.90 | 0.085 | |
| Arl6ip2 | ADP-ribosylation factor-like 6 interacting protein 2 isoform 1 | 1.90 | 0.126 | |
| Hspa5 | Heat shock 70 kDa protein 5 (glucose-regulated protein) | 1.86 | 0.076 | |
| 5830484A20Rik | Sp110 nuclear body protein | 1.86 | 0.066 | |
| Dnajb9 | DnaJ (Hsp40) homolog, subfamily B, member 9 | 1.81 | 0.008 | |
| Irgm | Interferon inducible protein 1 | 1.80 | 0.030 | |
| Stat1 | Signal transducer and activator of transcription 1 | 1.79 | 0.031 | |
| Dnajc3 | DnaJ (Hsp40) homolog, subfamily C, member 3 | 1.75 | 0.040 | |
| Myd116 | Myeloid differentiation primary response gene 116 | 1.75 | 0.088 | |
| D11Lgp2e | DNA segment, Chr 11, Lothar Hennighausen 2, expressed | 1.75 | 0.009 | |
| Ppp2r5e | Epsilon isoform of regulatory subunit B56, protein phosphatase 2A | 1.72 | 0.097 | |
| Dusp1 | Dual specificity phosphatase 1 | 1.71 | 0.185 | |
| Dnajc3 | DnaJ (Hsp40) homolog, subfamily C, member 3 | 1.71 | 0.106 | |
| Dnajb9 | DnaJ (Hsp40) homolog, subfamily B, member 9 | 1.69 | 0.002 | |
| Wdfy1 | WD repeat and FYVE domain containing 1 | 1.64 | 0.030 | |
| Slc7a11 | Solute carrier family 7 (cationic amino acid transporter, y+ system), member 11 | 1.63 | 0.111 | |
| Herpud1 | Homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 | 1.62 | 0.021 | |
| Igtp | Interferon gamma induced GTPase | 1.60 | 0.017 | |
| Mx2 | Myxovirus (influenza virus) resistance 2 | 1.60 | 0.002 |
The microarray data pertains to 36 h post-infection.
List of downregulated genes involved in pathogenesis of mouse neuroblastoma cells (N2A) infected with Japanese encephalitis virus.
| Accession no. | Gene name | Gene description | Fold change | |
|---|---|---|---|---|
| Lypd3 | GPI-anchored metastasis-associated protein homolog | −0.60 | 0.123 | |
| Gng4 | Guanine nucleotide binding protein (G protein), gamma 4 subunit | −0.60 | 0.107 | |
| Lix1 | Limb expression 1 homolog | −0.60 | 0.099 | |
| Synpo2 | −0.60 | 0.098 | ||
| Mrvi1 | MRV integration site 1 isoform a | −0.60 | 0.093 | |
| 8430429K09Rik | Hypothetical protein LOC71523 | −0.60 | 0.112 | |
| AK080781 | −0.60 | 0.105 | ||
| Lgi4 | Leucine-rich repeat LGI family, member 4 | −0.60 | 0.127 | |
| 4933400F03Rik | −0.60 | 0.153 | ||
| Itpr1 | Inositol 1,4,5-triphosphate receptor 1 | −0.60 | 0.096 | |
| AI427138 | −0.60 | 0.149 | ||
| Egln3 | EGL nine homolog 3 | −0.60 | 0.130 | |
| 4933402J24Rik | Hypothetical protein LOC74438 | −0.61 | 0.095 | |
| Pcdhb14 | Protocadherin beta 14 | −0.61 | 0.143 | |
| Pcdha9 | Protocadherin alpha 9 | −0.61 | 0.036 | |
| St6galnac4 | ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 | −0.61 | 0.112 | |
| 8430408O14 | −0.61 | 0.102 | ||
| Slc26a4 | Pendrin | −0.61 | 0.096 | |
| 1300007O09Rik | −0.61 | 0.102 | ||
| Tmem19 | Transmembrane protein 19 | −0.62 | 0.096 | |
| Frmpd1 | −0.62 | 0.099 | ||
| Gm608 | Hypothetical protein LOC207806 | −0.62 | 0.108 | |
| Pcdhb21 | Protocadherin beta 21 | −0.62 | 0.931 | |
| Myt1l | Myelin transcription factor 1-like | −0.63 | 0.088 | |
| Cbfa2t3h | Core-binding factor, runt domain, alpha subunit 2, translocated to, 3 homolog | −0.63 | 0.099 | |
| 6330439K17Rik | −0.63 | 0.095 | ||
| Gm288 | −0.63 | 0.156 | ||
| B3gnt6 | Beta-1,3-N-acetylglucosaminyltransferase bGnT-6 | −0.63 | 0.091 | |
| Smarcc1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 | −0.63 | 0.092 | |
| D630002J15Rik | −0.63 | 0.095 | ||
| Egfl7 | Vascular endothelial statin isoform 1 precursor | −0.63 | 0.095 | |
| Cstad | CSA-conditional, T cell activation-dependent protein | −0.63 | 0.092 | |
| Ceecam1 | Cerebral endothelial cell adhesion molecule 1 | −0.63 | 0.109 | |
| Lrrc24 | Leucine-rich repeat containing 24 | −0.64 | 0.087 | |
| C130057N11Rik | −0.64 | 0.142 | ||
| Tmem25 | Transmembrane protein 25 | −0.64 | 0.107 | |
| Pcyox1 | Prenylcysteine oxidase 1 | −0.64 | 0.089 | |
| Gprin1 | G protein-regulated inducer of neurite outgrowth 1 | −0.64 | 0.089 | |
| Aak1 | −0.64 | 0.105 | ||
| Col22a1 | −0.64 | 0.097 | ||
| Prkcz | Protein kinase C, zeta isoform b | −0.64 | 0.040 | |
| Stmn2 | Stathmin-like 2 | −0.65 | 0.092 | |
| Nope | Neighbor of Punc e11 protein | −0.65 | 0.106 | |
| Polr3g | −0.65 | 0.101 | ||
| C230014O12Rik | −0.65 | 0.131 | ||
| Tnik | −0.65 | 0.103 | ||
| Cspg5 | Chondroitin sulfate proteoglycan 5 | −0.65 | 0.104 | |
| Slc7a14 | Solute carrier family 7, member 14 | −0.65 | 0.097 | |
The microarray data pertains to 36 h post-infection.
Significant pathways of the upregulated genes at 36 h post-infection with JE virus.
| Pathways | No. of genes | |
|---|---|---|
| Protein export | 2 | 5.46E−06 |
| Toll-like receptor signaling pathway | 7 | 1.88E−05 |
| Circadian rhythm | 5 | 3.22E−05 |
| SNARE interactions in vesicular transport | 5 | 0.000157 |
| MAPK signaling pathway | 14 | 0.0005 |
| Alanine and aspartate metabolism | 3 | 0.002 |
| Aminoacyl-tRNA synthetases | 3 | 0.002 |
| Antigen processing and presentation | 4 | 0.004 |
| One carbon pool by folate | 2 | 0.005 |
| Jak-STAT signaling pathway | 5 | 0.008 |
| Methane metabolism | 1 | 0.023 |
| Novobiocin biosynthesis | 1 | 0.035 |
| N-glycan biosynthesis | 2 | 0.048 |
| Parkinson's disease | 2 | 0.050 |
| Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 1 | 0.053 |
| Retinol metabolism | 1 | 0.058 |
Significant pathways of the downregulated genes at 36 h post-infection with JE virus.
| Pathway | No. of genes | |
|---|---|---|
| Biosynthesis of steroids | 5 | 0.0006 |
| Androgen and estrogen metabolism | 1 | 0.013 |
| ECM-receptor interaction | 4 | 0.015 |
| Glycan structures – biosynthesis 2 | 2 | 0.019 |
| Diterpenoid biosynthesis | 1 | 0.021 |
| Focal adhesion | 6 | 0.024 |
| Alkaloid biosynthesis I | 1 | 0.031 |
Fig. 1Kinetics of JEV growth in Mouse N2A cells. Monolayers of N2A cells were infected with the JE S982 strain of JEV at an MOI of ∼5 and incubated at 37 °C. At various time intervals, samples were removed and virus titre was assayed. Values are mean ± SE of three replicates each.
Fig. 2Morphological pattern of neuroblastoma cells infected with JEV. Monolayers of the mouse neuroblastoma cells were adsorbed with either live JE virus (multiplicity of infection (MOI) ∼5) or mock-infected for 1 h, at 37 °C. (a) N2A cells mock-infected at 36 hpi; (b) N2A cells infected with JEV at 36 hpi; (c) N2A cells infected with JEV at 72 hpi; (d) N2A cells infected with JEV at 96 hpi.
Comparison of gene expression changes between microarray and qRT-PCR of some select genes in mouse neuroblastoma cells at 36 h post-infection with JE virus.
| Gene name | Description | Pathway | Microarray | Real-time RT-PCR |
|---|---|---|---|---|
| Itgb | Integrin beta | Focal adhesion, ECM-receptor interaction | +1 | +1.42 |
| CD40 | CD40 ligand | Toll-like receptor signaling | +1.06 | +1.6 |
| Tollip | Toll interacting protein | Toll-like receptor signaling | −0.61 | +1.40 |
| Xcr1 | Chemokine (C motif) receptor 1 | Cytokine–cytokine receptor interaction | −0.3 | −0.5 |
| Cxcl1 | Chemokine (C–X–C motif) ligand 1 | Cytokine–cytokine receptor interaction | +3.1 | +6.68 |
| Cxcl10 | Chemokine (C–X–C motif) ligand 10 | Toll-Like receptor signaling | +7.7 | +35.7 |
Fig. 3Chemokine expression by JEV-infected mouse neuroblastoma. N2A cells were infected with JEV, at least three replicates per time point were collected at different time intervals, and analysis was done with real-time RT-PCR. The expression of (A) CXCL9, (B) CXCL10 and (C) CXCL11 are shown. Values are mean ± SE of three replicates each. *Significantly different from control at p < 0.05 by Dunnet's test.